Skip to main content
. 2018 Oct 17;36(1):121–138. doi: 10.1007/s10815-018-1333-z

Table 6.

Risks of adverse outcomes, infant morbidity, and infant mortality by maternal fertility group and plurality at birth: twins

Very early preterm Early preterm Preterm SGA LGA NICU Neonatal Infant
Model #* 22–27 weeks 22–32 weeks 22–36 weeks (≤ − 1.28) (≥ 1.28) Admission Death Death
Infants Model 1 N 75,565 75,565 75,565 150,628 150,628 79,104 152,939 152,939
Outcome N, % 2760 3.7% 10,740 14.2% 44,090 58.3% 33,021 21.9% 2585 1.7% 25,421 32.1% 1939 1.27% 2506 1.64%
Model 2 N 58,110 58,110 58,110 115,847 115,847 61,505 117,837 117,837
N, % 1831 3.15% 8105 14.0% 34,530 59.4% 24,086 20.8% 2001 1.7% 20,371 33.1% 1122 0.95% 1451 1.23%
AOR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI
Fertility Model 1 Fertile 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference
Group Subfertile 1.77 1.44, 2.18 1.42 1.25, 1.61 1.14 1.04, 1.26 0.93 0.86, 1.01 0.94 0.74, 1.19 1.15 1.05, 1.26 1.40 1.08, 1.82 1.24 0.97, 1.57
IVF 0.88 0.81, 0.97 0.97 0.92, 1.02 1.07 1.03, 1.11 1.02 0.99, 1.05 0.83 0.76, 0.91 1.13 1.08, 1.19 0.69 0.61, 0.78 0.67 0.61, 0.75
IVF Model 2 Autologous, fresh 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference
Group Autologous, thawed 0.97 0.85, 1.12 1.01 0.94, 1.08 0.97 0.92, 1.02 0.60 0.57, 0.63 1.70 1.51, 1.91 0.96 0.90, 1.02 1.01 0.82, 1.24 0.97 0.81, 1.17
Donor, fresh 0.89 0.74, 1.07 1.15 1.05, 1.26 1.20 1.12, 1.28 0.83 0.78, 0.87 1.25 1.06, 1.47 1.15 1.07, 1.24 0.93 0.71, 1.21 0.97 0.77, 1.22
Donor, thawed 1.12 0.83, 1.52 1.23 1.06, 1.42 1.35 1.21, 1.51 0.77 0.70, 0.85 1.32 1.02, 1.72 1.09 0.96, 1.23 0.87 0.56, 1.35 0.78 0.52, 1.16
Co-morbidities Model 1 None 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference
Hypertension Pregestational 1.29 1.00, 1.67 1.26 1.10, 1.46 2.29 2.02, 2.59 1.18 1.08, 1.30 0.93 0.70, 1.23 1.39 1.20, 1.61 0.78 0.53, 1.13 0.83 0.60, 1.16
Gestational 0.45 0.37, 0.54 0.88 0.82, 0.95 2.29 2.15, 2.43 1.12 1.07, 1.17 1.05 0.91, 1.20 1.48 1.39, 1.57 0.56 0.43, 0.74 0.63 0.50, 0.79
Model 2 None 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference
Pregestational 0.51 0.41, 0.62 1.01 0.94, 1.09 2.62 2.46, 2.79 1.16 1.10, 1.22 0.86 0.74, 1.00 1.62 1.52, 1.72 0.53 0.39, 0.73 0.64 0.50, 0.83
Gestational 1.40 1.05, 1.87 1.37 1.17, 1.59 2.53 2.21, 2.90 1.25 1.12, 1.38 0.84 0.61, 1.14 1.46 1.25, 1.71 0.78 0.51, 1.19 0.83 0.57, 1.22
Co-morbidities Model 1 None 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference
Diabetes Pregestational 1.12 0.67, 1.87 1.58 1.23, 2.03 1.43 1.14, 1.79 0.96 0.80, 1.15 2.12 1.45, 3.11 1.58 1.28, 1.96 0.78 0.37, 1.66 1.05 0.58, 1.92
Gestational 0.64 0.52, 0.79 1.04 0.95, 1.14 1.08 1.01, 1.16 0.92 0.87, 0.97 1.39 1.20, 1.61 1.22 1.14, 1.31 0.89 0.68, 1.16 0.86 0.69, 1.09
Model 2 None 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference
Pregestational 0.70 0.56, 0.88 1.05 0.96, 1.16 1.09 1.01, 1.17 0.93 0.88, 0.99 1.29 1.09, 1.52 1.28 1.19, 1.37 0.81 0.59, 1.10 0.80 0.61, 1.05
Gestational 1.06 0.53, 2.11 1.34 0.97, 1.84 1.15 0.89, 1.50 1.08 0.88, 1.34 1.76 1.06, 2.92 1.58 1.22, 2.05 2.22 1.03, 4.78 2.16 1.09, 4.28
Length of Model 1 Term (≥37 weeks) 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference
Gestation Preterm (<37 weeks) 0.44 0.43, 0.46 1.89 1.70, 2.10 10.66 10.15, 11.19 2.64 1.98, 3.53 2.27 1.85, 2.79
Early Preterm (<32 weeks) 0.22 0.21, 0.23 4.58 4.07, 5.16 74.42 69.06, 80.20 17.85 13.45, 23.68 13.68 11.14, 16.81
Very early preterm (<28 weeks) 0.21 0.19, 0.23 8.84 7.71, 10.14 51.95 46.91, 57.53 499.48 386.61, 645.30 299.74 248.67, 361.30
Model 2 Term (≥37 weeks) 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference
Preterm (<37 weeks) 0.44 0.42, 0.45 1.86 1.65, 2.09 10.81 10.23, 11.42 2.79 1.93, 4.05 2.39 1.80, 3.17
Early Preterm (<32 weeks) 0.22 0.21, 0.24 3.96 3.45, 4.53 73.27 67.36, 79.70 22.27 15.57, 31.85 17.80 13.51, 23.45
Very early preterm (<28 weeks) 0.19 0.17, 0.21 8.64 7.37, 10.14 65.40 57.42, 74.48 540.5 387.13, 754.63 380.01 293.77, 491.55
Placental Model 1 None 1.00 Reference 1.00 Reference 1.00 Reference
Complications Other excessive bleeding 1.17 0.80, 1.70 1.20 0.97, 1.49 1.08 0.91, 1.28
Placenta previa 0.75 0.36, 1.55 1.79 1.36, 2.37 3.48 2.56, 4.71
Abruptio placenta 5.79 4.52, 7.41 5.13 4.28, 6.16 3.61 2.85, 4.57
Model 2 None 1.00 Reference 1.00 Reference 1.00 Reference
Other excessive bleeding 0.71 0.43, 1.19 1.02 0.81, 1.29 0.95 0.79, 1.13
Placenta previa 0.94 0.49, 1.81 2.00 1.54, 2.60 3.63 2.69, 4.90
Abruptio placenta 6.84 5.21, 8.99 5.23 4.28, 6.38 3.21 2.50, 4.13

The N for the very early preterm, early preterm, and preterm outcomes is based on pregnancies, not infants. Models adjusted for maternal age, parity, hypertension and diabetes (pregestational and gestational), placental complications (placenta previa, abruptio placenta, and excessive bleeding), mode of delivery, infant sex, length of gestation, small-for-gestation birthweight, State of residence, year of birth, and fertility status. For model 1, the study population was categorized by fertility status as fertile (reference), subfertile, and IVF (limited to autologous-fresh cycles only); for model 2, the study population was limited to IVF-conceived pregnancies as autologous-fresh (reference), autologous-thawed, donor-fresh, donor-thawed. Italicized AORs and 95% CIs are increased; those that are additionally emphasized in bold are significantly increased